In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML

Anmaar M. Abdul-Nabi, Enas R. Yassin, Nobish Varghese et al. · 2010

Read In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML by Anmaar M. Abdul-Nabi, Enas R. Yassin, Nobish Varghese et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012464.txt.

Description

Anmaar Abdul-Nabi, Enas Yassin, Nobish Varghese and colleagues transformed human blood stem cells in a dish with leukemia fusion genes, in a 2010 PLOS ONE paper. Acute myeloid leukemia often starts when two genes fuse into an abnormal one. Each fusion gives the disease its own look and course, suggesting each transforms cells its own way.

By adding fusions to primary human CD34 cells and reading early gene changes, the team found candidate drug targets among the first switches thrown. Early changes are the closest to the root cause, before secondary chaos sets in. The dish model lets scientists test fusion-specific drugs without waiting for rare patient samples.

Catalog record

CREATORAnmaar M. Abdul-Nabi, Enas R. Yassin, Nobish Varghese et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012464

Browse the full library · About the Tower of Babel